Presentation is loading. Please wait.

Presentation is loading. Please wait.

Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011  Diana Díaz-Jiménez, Esp, Carlos Castañeda-Orjuela, MD, MSc, Liliana Castillo-Rodríguez,

Similar presentations


Presentation on theme: "Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011  Diana Díaz-Jiménez, Esp, Carlos Castañeda-Orjuela, MD, MSc, Liliana Castillo-Rodríguez,"— Presentation transcript:

1 Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011 
Diana Díaz-Jiménez, Esp, Carlos Castañeda-Orjuela, MD, MSc, Liliana Castillo-Rodríguez, MSc, Fernando De la Hoz-Restrepo, MD, PhD  Value in Health Regional Issues  Volume 8, Pages (December 2015) DOI: /j.vhri Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2 Fig. 1 Low and upper limits for annual salaries according to the year of loss in 2012 US dollars. AMW, annual minimum wage; pcGDP, per capita gross domestic product. Value in Health Regional Issues 2015 8, DOI: ( /j.vhri ) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3 Fig. 2 Avoidable mortality costs in working age by year and sex: Colombia (1998–2011) (in thousands of 2012 USD). Value in Health Regional Issues 2015 8, DOI: ( /j.vhri ) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4 Fig. 3 Avoidable mortality costs in the best-case scenario per 22 GBD group causes: Colombia (1998–2011). HIV, HIV/AIDS; TB, Tuberculosis; Dia, Diarrhea; LRI, Lower respiratory infections; Oth, other common infectious diseases; NTD, Neglected tropical diseases; Maternal, Maternal disorders; Neonatal, Neonatal disorders; Ntr Def, Nutritional deficiencies; CVD, Cardiovascular and circulatory diseases; Chr Resp, Chronic respiratory diseases; Neuro, Neurological disorders; Mental, Mental and behavioral disorders; Diab, Diabetes; Urog, urogenital; Hem, blood; MSK, Musculosketeal disorders; NCD, Other non-communicable diseases; Tran Inj, Transport injuries; Unint Inj, Unintentional injuries other than transport injuries; Intent Inj, Self-harm and interpersonal violence; disaster, forces of nature; Undet int Inj, Injuries with undetermined intent; GBD, global burden disease. Value in Health Regional Issues 2015 8, DOI: ( /j.vhri ) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

5 Fig. 4 Avoidable mortality costs in the worst-case scenario per 22 GBD group causes: Colombia (1998–2011). HIV, HIV/AIDS; TB, Tuberculosis; Dia, Diarrhea; LRI, Lower respiratory infections; Oth, other common infectious diseases; NTD, Neglected tropical diseases; Maternal, Maternal disorders; Neonatal, Neonatal disorders; Ntr Def, Nutritional deficiencies; CVD, Cardiovascular and circulatory diseases; Chr Resp, Chronic respiratory diseases; Neuro, Neurological disorders; Mental, Mental and behavioral disorders; Diab, Diabetes; Urog, urogenital; Hem, blood; MSK, Musculosketeal disorders; NCD, Other non-communicable diseases; Tran Inj, Transport injuries; Unint Inj, Unintentional injuries other than transport injuries; Intent Inj, Self-harm and interpersonal violence; disaster, forces of nature; Undet int Inj, Injuries with undetermined intent; GBD, global burden disease. Value in Health Regional Issues 2015 8, DOI: ( /j.vhri ) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions


Download ppt "Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011  Diana Díaz-Jiménez, Esp, Carlos Castañeda-Orjuela, MD, MSc, Liliana Castillo-Rodríguez,"

Similar presentations


Ads by Google